한국어
English
日本語
中文(简体)
Inhiplat Tablets (Clopidogrel Camisilate)
129.14mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Clopidogrel camylsate is an ingredient that inhibits platelet aggregation to prevent thrombus formation.
MFDS ingredient code M251340
Clopidogrel camylsate belongs to the class of antiplatelet agents that regulate platelet function. It is primarily used to prevent thrombus formation due to atherosclerosis. It reduces the generation of thrombus within blood vessels by preventing platelets in the blood from clumping together.
This ingredient blocks the ADP receptors on the platelet surface, interfering with the process by which platelets adhere to each other. As a result, it decreases the formation of thrombus, lowering the risk of vascular obstruction. It plays a role in maintaining smooth blood flow.
Approved uses differ by product. Check each product's information for its actual use.
Unlike aspirin, clopidogrel camylsate targets ADP receptors to inhibit platelet aggregation. This can lead to a complementary effect when used in combination with aspirin. Moreover, compared to other antiplatelet agents, it tends to have a good balance between bleeding risk and efficacy.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
